All Stories

  1. QbD-Based Systematic Development of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Biochanin A with Enhanced Biopharmaceutical Attributes

    Article • BioNanoScience, December 2025, Springer Science + Business Media

    Dr Vikas Anand Saharan

  2. Formulating Pharma‐, Nutra‐, and Cosmeceutical Products from Herbal Substances

    Article • August 2025, Wiley

    Dr Vikas Anand Saharan

  3. A comprehensive update on cannabidiol, its formulations and drug delivery systems

    Article • Phytochemistry Reviews, August 2024, Springer Science + Business Media

    Mr. Surojit Banerjee, Dr Vikas Anand Saharan

  4. Solubility-permeability interplay of hydrotropic solubilization of piroxicam

    Article • Drug Development and Industrial Pharmacy, May 2024, Taylor & Francis

    Mr. Surojit Banerjee, Dr Vikas Anand Saharan

  5. A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19

    Article • Vaccines, February 2023, MDPI AG

    Mr. Surojit Banerjee, Dr Vikas Anand Saharan

  6. PEGylated G4 dendrimers as a promising nanocarrier for piperlongumine delivery: Synthesis, characterization, and anticancer activity

    Article • European Polymer Journal, October 2022, Elsevier

    Dr Vikas Anand Saharan

  7. Smart approaches for encouraging the blood donation

    Article • Asian Journal of Transfusion Science, September 2022, Wolters Kluwer Health

    Dr Vikas Anand Saharan

  8. A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines

    Article • AAPS PharmSciTech, March 2022, Springer Science + Business Media

    Mr. Surojit Banerjee, Dr Vikas Anand Saharan

  9. Computer Aided Pharmaceutics and Drug Delivery

    Article • January 2022, Springer Science + Business Media

    Dr Vikas Anand Saharan

  10. Authorship and Contributorship in Scientific Publications

    Article • November 2021, American Chemical Society (ACS)

    Dr Vikas Anand Saharan

  11. Lipids for Taste masking and Taste assessment in pharmaceutical formulations

    Article • Chemistry and Physics of Lipids, March 2021, Elsevier

    Mr. Surojit Banerjee, Dr Vikas Anand Saharan

  12. Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines

    Article • Recent Patents on Drug Delivery & Formulation, October 2020, Bentham Science Publishers

    Dr Vikas Anand Saharan

  13. Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery

    Article • Recent Patents on Drug Delivery & Formulation, October 2020, Bentham Science Publishers

    Dr Vikas Anand Saharan

  14. Solubility-Permeability Interplay of Hydrotropic Solubilization Using Response Surface Methodology

    Article • Drug Delivery Letters, September 2020, Bentham Science Publishers

    Dr Vikas Anand Saharan

  15. Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement

    Article • Advanced Pharmaceutical Bulletin, August 2020, MaadRayan Publishing Company

    Dr Vikas Anand Saharan

  16. Development and Evaluation of IER based Formulation of Ondansetron HCl

    Article • International Journal of Pharmaceutical Research, June 2020, SynthesisHub Advance Scientific Research

    Dr Vikas Anand Saharan

  17. The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations

    Article • Current Drug Targets, October 2019, Bentham Science Publishers

    Dr Vikas Anand Saharan

  18. Transdermal applications of ethosomes – a detailed review

    Article • Journal of Liposome Research, October 2018, Taylor & Francis

    Dr Vikas Anand Saharan

  19. Analysis of Solution and System Identification of Coupled Fractional Delay Differential Equation by Shifted Jacobi Polynomials

    Article • March 2018, Bentham Science Publishers

    Dr Vikas Anand Saharan, Muthukumar Palanisamy, P. Balasubramaniam

  20. Approved and Marketed Fast Dissolving/ Disintegrating Drug Products

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  21. Clinical Studies on Fast Dissolving/Disintegrating Dosage Forms

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  22. Excipients for Fast Dissolving /Disintegrating Tablets

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  23. Fast Dissolving/Disintegrating Dosage Forms: Introducing through Development, Market, Pharmacopoeial and Regulatory Status

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  24. Freeze Drying Technologies for Developing Fast Dissolving/Disintegrating Tablets

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  25. Modifications in Conventional Tablet Compaction Technologies for Developing Fast Dissolving/ Disintegrating Tablets

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  26. Novel Fast Dissolving/Disintegrating Dosage Forms

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  27. Quality Assurance and Evaluation of Fast Dissolving/Disintegrating Dosage Forms

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  28. Taste Masking in Fast Dissolving/Disintegrating Dosage Forms

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  29. Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms

    Article • May 2017, Bentham Science Publishers

    Dr Vikas Anand Saharan

  30. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate

    Article • Turkish Journal of Pharmaceutical Sciences, April 2017, Journal of Clinical Research of Pediatric Endocrinology

    Dr Vikas Anand Saharan

  31. Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems

    Article • Drug Development and Industrial Pharmacy, January 2016, Taylor & Francis

    Dr Vikas Anand Saharan, Hemant Jadhav

  32. taste assessment

    Article • Recent Patents on Drug Delivery & Formulation, September 2015, Bentham Science Publishers

    Dr Vikas Anand Saharan

  33. Formulation and evaluation of lipid based taste masked granules of ondansetron HCl

    Article • European Journal of Pharmaceutical Sciences, October 2014, Elsevier

    Dr Vikas Anand Saharan, Hemant Jadhav

  34. Bitterness Score and its Correlation to Drug Concentration: An Approach for Estimating Bitterness Suppression in a Marketed Product of Ofloxacin

    Article • Analytical Chemistry Letters, July 2014, Taylor & Francis

    Dr Vikas Anand Saharan, Hemant Jadhav

  35. Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design

    Article • International Current Pharmaceutical Journal, June 2014, Bangladesh Journals Online (BanglaJOL)

    Dr Vikas Anand Saharan

  36. A Proposed Methodology for In Vitro Evaluation of Bitterness in Drug Solutions and In Vitro Drug Release Samples

    Article • Journal of Pharmaceutical Innovation, April 2014, Springer Science + Business Media

    Dr Vikas Anand Saharan, Hemant Jadhav

  37. Anti-histaminic Activity ofDesmostachya bipinnata

    Article • Journal of Biologically Active Products from Nature, January 2014, Taylor & Francis

    Dr Vikas Anand Saharan

  38. Pharmacognostic standardization with various plant parts ofDesmostachya bipinnata

    Article • Pharmaceutical Biology, October 2013, Taylor & Francis

    Dr Vikas Anand Saharan

  39. Formulation, evaluation and 32full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres

    Article • Pharmaceutical Development and Technology, September 2013, Taylor & Francis

    Dr Vikas Anand Saharan, Hemant Jadhav

  40. Phytosomes: Complexation, Utilisation and Commerical Status

    Article • Journal of Biologically Active Products from Nature, January 2012, Taylor & Francis

    Dr Vikas Anand Saharan, Dr Prithviraj Chakraborty

  41. Strychnos nux-vomica seeds: Pharmacognostical standardization, extraction, and antidiabetic activity

    Article • Journal of Ayurveda and Integrative Medicine, January 2012, Elsevier

    Dr Vikas Anand Saharan

  42. Dissolution rate enhancement of gliclazide by ordered mixing

    Article • Acta Pharmaceutica, January 2011, De Gruyter

    Dr Vikas Anand Saharan

  43. Effect of time on extraction of Ashwagandha in various Hydroalcoholic compositions and their anti-inflammatory activity

    Article • International Journal of Green Pharmacy, January 2011, BRNSS Publication Hub

    Dr Vikas Anand Saharan

  44. Dissolution enhancement of drugs. part i: technologies and effect of carriers

    Article • International Journal of Health Research, June 2010, African Journals Online (AJOL)

    Dr Vikas Anand Saharan

  45. Mechanical Methods for Dry Particle Coating Processes and Their Applications in Drug Delivery and Development

    Article • Recent Patents on Drug Delivery & Formulation, January 2010, Bentham Science Publishers

    Dr Vikas Anand Saharan

  46. Dissolution Enhancement of Drugs. Part II: Effect of Carriers

    Article • International Journal of Health Research, November 2009, African Journals Online (AJOL)

    Dr Vikas Anand Saharan

  47. Design and Development of Gliclazide Mucoadhesive Microcapsules: In Vitro and In Vivo Evaluation

    Article • AAPS PharmSciTech, February 2008, American Association of Pharmaceutical Scientists (AAPS)

    Dr Vikas Anand Saharan

  48. The latest trends in the taste assessment of pharmaceuticals

    Article • Drug Discovery Today, March 2007, Elsevier

    Dr Vikas Anand Saharan

  49. Ion-exchange resins: carrying drug delivery forward

    Article • Drug Discovery Today, September 2001, Elsevier

    Dr Vikas Anand Saharan